Department of Colorectal Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Front Endocrinol (Lausanne). 2022 Jul 21;13:871830. doi: 10.3389/fendo.2022.871830. eCollection 2022.
Regional lymph node metastasis (LNM) is crucial for planning additional lymphadenectomy, and is directly correlated with poor prognosis in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). However, the patterns of LNM for small (≤20 mm) GEP-NETs remain unclear. This population-based study aimed at evaluating LNM patterns and identifying optimal surgical strategies from the standpoint of lymph node dissemination.
This retrospective cohort study retrieved data from the Surveillance, Epidemiology, and End Results (SEER) 18 registries database for 17,308 patients diagnosed as having localized well-differentiated GEP-NETs ≤ 20 mm between January 1, 2004, and December 31, 2017. The patterns of LNM were characterized in 6,622 patients who underwent extended resection for adequate lymph node harvest.
Of 6,622 patients with localized small GEP-NETs in the current study, 2,380 (36%) presented with LNM after regional lymphadenectomy. Nodal involvement was observed in approximately 7.4%, 49.1%, 13.6%, 53.7%, 13.8%, 7.8%, and 15.4% of gastric (g-), small intestinal (si-), appendiceal (a-), colonic (c-), rectal (r-), non-functional pancreatic (nfp-), and functional pancreatic (fp-) NETs ≤ 20 mm. Patients with younger age, larger tumor size, and muscularis invasion were more likely to present with LNM. Additional lymphadenectomy conferred a significant survival advantage in NETs (≤10 mm: HR, 0.47; 95% CI, 0.33-0.66; < 0.001; 11-20 mm: HR, 0.54; 95% CI, 0.34-0.85; = 0.008) and fp-NETs ≤ 20 mm (HR, 0.08; 95% CI, 0.02-0.36; = 0.001), as well as g-NETs (HR, 0.39; 95% CI, 0.16-0.96; = 0.041) and c-NETs of 11-20 mm (HR, 0.07; 95% CI, 0.01-0.48; = 0.007). Survival benefits of additional lymphadenectomy were not found in a-NETs, r-NETs, and nfp-NETs with a small size.
Given the increased risk for nodal metastasis, primary tumor resection with regional lymphadenectomy is a potential optimal surgical strategy for si-NETs and fp-NETs ≤ 20 mm, as well as g-NETs and c-NETs of 11-20 mm. Local resection is an appropriate and reliable surgical approach for a-NETs, r-NETs, and nfp-NETs ≤ 20 mm.
区域淋巴结转移(LNM)对于计划进行额外的淋巴结清扫至关重要,并且与胃肠胰神经内分泌肿瘤(GEP-NETs)的不良预后直接相关。然而,对于直径≤20mm 的小 GEP-NETs 的 LNM 模式仍不清楚。本基于人群的研究旨在评估 LNM 模式,并从淋巴结扩散的角度确定最佳的手术策略。
本回顾性队列研究从 2004 年 1 月 1 日至 2017 年 12 月 31 日期间的监测、流行病学和最终结果(SEER)18 登记处数据库中检索了 17308 例诊断为局限性分化良好的直径≤20mm 的 GEP-NETs 患者的数据。对 6622 例接受了充分淋巴结采集的扩大切除术的患者进行了 LNM 模式特征分析。
在本研究中,6622 例局限性小 GEP-NETs 患者中,2380 例(36%)在区域淋巴结清扫后出现 LNM。胃(g-)、小肠(si-)、阑尾(a-)、结肠(c-)、直肠(r-)、非功能性胰腺(nfp-)和功能性胰腺(fp-)NETs 中,淋巴结受累分别见于约 7.4%、49.1%、13.6%、53.7%、13.8%、7.8%和 15.4%的肿瘤直径≤20mm 的患者。年龄较小、肿瘤较大和肌层浸润的患者更有可能出现 LNM。额外的淋巴结清扫在 NETs(≤10mm:HR 0.47;95%CI 0.33-0.66;<0.001;11-20mm:HR 0.54;95%CI 0.34-0.85; = 0.008)和 fp-NETs ≤ 20mm(HR 0.08;95%CI 0.02-0.36; = 0.001)以及 g-NETs(HR 0.39;95%CI 0.16-0.96; = 0.041)和 c-NETs 11-20mm(HR 0.07;95%CI 0.01-0.48; = 0.007)中均带来了显著的生存获益。在直径较小的 a-NETs、r-NETs 和 nfp-NETs 中,未发现额外的淋巴结清扫的生存获益。
鉴于淋巴结转移的风险增加,对于直径≤20mm 的 si-NETs 和 fp-NETs,以及直径 11-20mm 的 g-NETs 和 c-NETs,原发肿瘤切除术联合区域淋巴结清扫可能是一种潜在的最佳手术策略。对于直径≤20mm 的 a-NETs、r-NETs 和 nfp-NETs,局部切除术是一种合适且可靠的手术方法。